A Multilevel, Multiphase Optimization Strategy for PrEP (MOST:PrEP)
Part of paid clinical trials in Detroit, Michigan.
- Sponsor
- Henry Ford Health System
- Study ID
- NCT06334341
- Status
- Enrolling By Invitation
Conditions
- HIV Seropositivity
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Computer-based simulation training for providers — BEHAVIORALA Computer-Based Simulation training for providers, based on the Centers for Disease Control and Prevention "Guide for Healthcare Professional: Discussing Sexual Health with Your Patients", current PrEP information, and the Social Cognitive Theory. This is a single-session, 30-minute training module contains educational information with animated narration about PrEP, how to take a sexual health history, understanding internal bias, potential patient barriers to PrEP as well as recorded video-simulated encounters, in which providers view different types of patient/provider interactions.
- Best Practice Alert — BEHAVIORALA Best Practice Alert will alert providers to patients who are part of the Centers for Disease Control and Prevention PrEP priority populations.
- HIV Risk Assessment — BEHAVIORALA risk assessment tool that considers the behaviors - i.e., types of sexual activities, protective behaviors (condoms, PrEP, ART), and other factors (HIV status, sexually transmitted infections) of the respondent.
- PrEP Informational Video — BEHAVIORALA short informational video, tailored to the local Detroit context with themes that will focus on introducing PrEP, stigma surrounding taking PrEP, and potential barriers and how to overcome them.
Study Details
What is known: There are 1.2 million people in the US who meet the indications for PrEP; yet, disparities exist in uptake. For example, only 9% of Black and 16% of Latino individuals, compared to 65% of White individuals, have been prescribed PrEP. At Henry Ford Health (HFH) system, only 10% of eligible patients have been prescribed PrEP. Primary care is an ideal setting for PrEP to be offered as an HIV prevention method since providers see large numbers of patients who are HIV negative, with some who are at increased risk for HIV, and the primary care setting is often the point of entry to the healthcare system. The multiphase optimization strategy (MOST) framework is a novel, innovative way to identify an efficient intervention. What will be done: In this optimization trial, the investigators will test the effectiveness of intervention components, alone and in combination, on new PrEP prescriptions in primary care at HFH. First, feedback will be generated on context-specific (system and individual level) factors for intervention component delivery via focus groups with providers (n=15) and patients eligible for PrEP (n=30). Then, four intervention components will be tested in an optimization trial, with 16 conditions being implemented at 32 clinics. Finally, feedback will be generated on the factors that affected implementation via semi-structured interviews with providers (n=30) and patients (n=30). Participants will be primary care providers (PCPs) and patients eligible for PrEP in Henry Ford Health System. Clinics will be randomized (yes/no) to receive any combination of provider and patient intervention components. Provider intervention components include computer-based simulation training and/or best practice alerts delivered via the electronic health record (EHR). Patient intervention components include HIV risk assessment and/or PrEP informational video - both delivered via the EHR. Primary outcome is the rate of new PrEP prescriptions at the clinic level. Secondary outcomes will include PrEP maintenance, number of HIV tests ordered by a PCP, and number of PCPs trained. Sub analyses will test which factors moderate (e.g., patient sex, race, age, gender, sexual orientation) or mediate (e.g., perceived HIV risk, provider and patient PrEP knowledge) PrEP uptake, focusing on priority populations and disparities in rates of PrEP prescription. Implications: 1) Understanding which intervention components lead to increased PrEP prescriptions will represent an important advance in HIV prevention efforts. 2) Optimizing a multi-level intervention for providers and patients to increase PrEP prescriptions would lead to a new, efficient, evidence-based option. 3) Determining what factors are related to PrEP uptake will help reduce disparities in PrEP initiation among those most in need. 4) Understanding the context specific factors related to intervention component implementation will help identify best methods for replication/adaptation in other healthcare systems.
Key Dates
- Start date
- Feb 21, 2024
- Status verified
- May 2025
- Primary completion
- Apr 30, 2028
- Completion
- Apr 30, 2028
Study Design
- Enrollment
- 1,380 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- FACTORIAL
- Primary purpose
- PREVENTION
Arms
- No Intervention: No interventionNo intervention
- Experimental: VideoPatient PrEP Video only
- Experimental: Risk AssessmentPatient Risk Assessment only
- Experimental: Risk Assessment and VideoPatient Risk Assessment and Patient PrEP Video
- Experimental: Best Practice AlertBest Practice Alert only
- Experimental: Best Practice Alert and VideoBest Practice Alert and Patient PrEP Video
- Experimental: Best Practice Alert and Risk AssessmentBest Practice Alert and Patient Risk Assessment
- Experimental: Best Practice Alert, Risk Assessment and VideoBest Practice Alert, Patient Risk Assessment, and Patient PrEP Video
- Experimental: TrainingProvider Training
- Experimental: Training and VideoProvider Training and Patient PrEP Video
- Experimental: Training and Risk AssessmentProvider Training and Patient Risk Assessment
- Experimental: Training, Risk Assessment, and VideoProvider Training, Patient Risk Assessment, and Patient PrEP Video
- Experimental: Training and Best Practice AlertProvider Training and Best Practice Alert
- Experimental: Training, Best Practice Alert, and VideoProvider Training, Best Practice Alert, and Patient PrEP Video
- Experimental: Training, Best Practice Alert, and Risk AssessmentProvider Training, Best Practice Alert, and Patient Risk Assessment
- Experimental: Training, Best Practice Alert, Risk Assessment, and VideoProvider Training, Best Practice Alert, Patient Risk Assessment, and Patient PrEP Video
Primary Outcome Measure
Clinic-Level PrEP Prescription [ Time Frame: Year 1 and Year 5 electronic health record data pull. ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Henry Ford Health | Detroit | Michigan | 48202 | - |
Find similar trials in Detroit, MI
Related Studies
- Hybrid Type I Effectiveness-Implementation Trial of a Social Network Support InterventionRecruiting · University of Chicago · Birmingham, Alabama